Wu SD - Search Results

1

Immune modulation of gut microbiota and its metabolites in chronic hepatitis B.

Li SQ, Shen Y, Zhang J, Weng CZ, Wu SD, Jiang W. Li SQ, et al. Among authors: wu sd. Front Microbiol. 2023 Nov 29;14:1285556. doi: 10.3389/fmicb.2023.1285556. eCollection 2023. Front Microbiol. 2023. PMID: 38094621 Free PMC article. Review.

2

Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.

Shen Y, Wu SD, Chen Y, Li XY, Zhu Q, Nakayama K, Zhang WQ, Weng CZ, Zhang J, Wang HK, Wu J, Jiang W. Shen Y, et al. Among authors: wu sd, wu j. Gut Microbes. 2023 Jan-Dec;15(1):2155018. doi: 10.1080/19490976.2022.2155018. Gut Microbes. 2023. PMID: 36519342 Free PMC article.

3

IFN-γ facilitates liver fibrogenesis by CD161⁺CD4⁺ T cells through a regenerative IL-23/IL-17 axis in chronic hepatitis B virus infection.

Li J, Cheng L, Jia H, Liu C, Wang S, Liu Y, Shen Y, Wu S, Meng F, Zheng B, Yang C, Jiang W. Li J, et al. Clin Transl Immunology. 2021 Nov 2;10(11):e1353. doi: 10.1002/cti2.1353. eCollection 2021. Clin Transl Immunology. 2021. PMID: 34754450 Free PMC article.

4

Diagnostic role of transient elastography in patients with autoimmune liver diseases: A systematic review and meta-analysis.

Chen H, Shen Y, Wu SD, Zhu Q, Weng CZ, Zhang J, Wang MX, Jiang W. Chen H, et al. Among authors: wu sd. World J Gastroenterol. 2023 Oct 21;29(39):5503-5525. doi: 10.3748/wjg.v29.i39.5503. World J Gastroenterol. 2023. PMID: 37900994 Free PMC article.

5

Type 3 innate lymphoid cell: a new player in liver fibrosis progression.

Wang S, Li J, Wu S, Cheng L, Shen Y, Ma W, She W, Yang C, Wang J, Jiang W. Wang S, et al. Clin Sci (Lond). 2018 Dec 13;132(24):2565-2582. doi: 10.1042/CS20180482. Print 2018 Dec 21. Clin Sci (Lond). 2018. PMID: 30459204

6

The prognostic role of liver stiffness in patients with chronic liver disease: a systematic review and dose-response meta-analysis.

Shen Y, Wu SD, Wu L, Wang SQ, Chen Y, Liu LL, Li J, Yang CQ, Wang JY, Jiang W. Shen Y, et al. Among authors: wu sd, wu l. Hepatol Int. 2019 Sep;13(5):560-572. doi: 10.1007/s12072-019-09952-5. Epub 2019 Jul 4. Hepatol Int. 2019. PMID: 31273618

7

Entecavir-induced interferon-λ1 suppresses type 2 innate lymphoid cells in patients with hepatitis B virus-related liver cirrhosis.

Wang SQ, Shen Y, Li J, Liu Y, Cheng LS, Wu SD, She WM, Jiang W. Wang SQ, et al. Among authors: wu sd. J Viral Hepat. 2021 May;28(5):795-808. doi: 10.1111/jvh.13476. Epub 2021 Feb 2. J Viral Hepat. 2021. PMID: 33482039

8

Clinical application of liver stiffness measurement in patients with cavernous transformation of portal vein.

Shen Y, Ma W, Hang Y, Liu LL, Jiang W, Wu SD. Shen Y, et al. Among authors: wu sd. Exp Ther Med. 2021 May;21(5):442. doi: 10.3892/etm.2021.9881. Epub 2021 Feb 28. Exp Ther Med. 2021. PMID: 33777190 Free PMC article.

9

Accuracy of transient elastography in assessing fibrosis at diagnosis in individuals with autoimmune liver disease.

Shen Y, Chen H, Wu SD, Jiang W. Shen Y, et al. Among authors: wu sd. J Hepatol. 2023 Jan;78(1):e33-e34. doi: 10.1016/j.jhep.2022.08.013. Epub 2022 Aug 18. J Hepatol. 2023. PMID: 35988686 No abstract available.

10

Predictors of relapse after cessation of nucleos(t)ide analog treatment in HBeAg-negative chronic hepatitis B patients: A meta-analysis.

Liu Y, Jia M, Wu S, Jiang W, Feng Y. Liu Y, et al. Int J Infect Dis. 2019 Sep;86:201-207. doi: 10.1016/j.ijid.2019.07.036. Epub 2019 Aug 5. Int J Infect Dis. 2019. PMID: 31394205 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

233 results

Search Page

Filters